|
|
Vaccine Detail
|
live attenuated Brucella abortus per mutant vaccine |
| Vaccine Information |
- Vaccine Name: live attenuated Brucella abortus per mutant vaccine
- Target Pathogen: Brucella spp.
- Target Disease: Brucellosis
- Vaccine Ontology ID: VO_0009154
- Type: Live attenuated vaccine
- Status: Research
- Host Species for Licensed Use: Cattle
- Host Species as Laboratory Animal Model: Mus musculus
- Antigen: per gene mutant (perosamine synthetase)
- Preparation: Live attenuated rough lipopolysaccharide mutant with per gene disruption. (Monreal et al, 2003)
- Description: The per mutant was evaluated as a rough vaccine candidate in mice. Efficacy: Induced protection against Brucella abortus but less than the standard smooth vaccine strain 19; afforded similar protection to strain 19 against Brucella ovis. Immune response: Induced antibodies to rough LPS and outer membrane proteins; protection attributed largely to anti O-polysaccharide antibodies. (Monreal et al, 2003)
|
| Host Response |
|
Mouse Response
- Immune Response: Induced antibodies to rough LPS and outer membrane proteins; protection attributed largely to anti O-polysaccharide antibodies. (Monreal et al, 2003)
- Challenge Protocol: Mouse model challenge experiments. (Monreal et al, 2003)
- Efficacy: Induced protection against Brucella abortus but less than the standard smooth vaccine strain 19; afforded similar protection to strain 19 against Brucella ovis. (Monreal et al, 2003)
- Description: Mouse model challenge experiments. (Monreal et al, 2003)
|
| References |
Monreal et al, 2003: Monreal D, Grilló MJ, González D, Marín CM, De Miguel MJ, López-Goñi I, Blasco JM, Cloeckaert A, Moriyón I. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infection and immunity. 2003 Jun; 71(6); 3261-71. [PubMed: 12761107].
|
|